Empowered Patient Podcast

New Therapies for Advanced Colorectal Cancer with Anders Rabbe Isofol Medical

Informações:

Sinopse

Anders Rabbe, CEO, Isofol Medical discusses the developments of new therapies for patients with advanced colorectal cancer, a devastating disease with limited treatment options.  Isofol is developing arfolitixorin to increase the efficacy of standard of care chemotherapy and is actively enrolling patients in a global Phase 3 clinical trial. #CRC #ColonCancer #ColorectalCancer #FightCRC #FightCancer Isofol Medical